PPARG and type 2 diabetes mellitus: For instance, increasing subcutaneous fat mass via inducing adipogenesis is considered as a beneficial mechanism for the anti-diabetic effect of thiazolidinediones, a class of peroxisome proliferator activated receptor gamma (Pparg) agonists in insulin resistance and type 2 diabetes [32,33,34,35].